Skip to content

Role of Mamajjaka (An Ayurvedic Medicine) in the form of Churna and Ghanavati in the Management of Madhumeha (DM-2

A Comparative Study of Mamajjaka Churna and Mamajjaka Ghanvati in the Management of Madhumeh (DM-2) in the Preview of â??à¤?षायà¤?पनाायातरà¥?बलापà¥?णà¥?â?? (à¤?.स.à¥?4/7)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035011
Enrollment
50
Registered
2021-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Mamajjaka Churna: Mamajjaka Churna, 3gm twice in a day empty stomach in the morning and after dinner with luke warm water. Control Intervention1: Mamajjaka Ghanavat: Mamajjaka Ghanavat,

Sponsors

National Institute Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: . With the classical sign and symptoms of Madhumeha. 2. Diagnosed case of Madhumeha w.s.r. to Diabetes mellitus Type-2 (NIDDM) i.e. FBS >=126mg/dl to 160mg/dl or PPBS 200mg/dl to 250mg/dl. 3. HbA1c is between 6.5% to 8.0%. 4. Only uncomplicated cases of type-2 diabetes. 5. Patient willing to signature the consent form for the clinical trial.

Exclusion criteria

Exclusion criteria: Patient having Diabetes mellitus Type1[IDDM]. 2. Age below 18 and above 70 years. 3. Patient of Diabetes mellitus Type-2 who are on insulin therapy. 4. Patient having any serious illness such as Renal, Hepatic and Cardiac involvement. 5. FBS more than 160mg/dl. 6. PPBS more than 250mg/dl (after two hour). 7. Diabetes mellitus with serious complications. 8. Uncontrolled Hypertension. 9. Pregnant women.

Design outcomes

Primary

MeasureTime frame
changes in blood sugar level.Timepoint: 90 Days.

Secondary

MeasureTime frame
Effect of two therapies on symptoms of MadhumehaTimepoint: 90Days

Countries

India

Contacts

Public ContactDr Rajendra Singh

National Institute of Ayurveda

dr_bhuvnesh@yahoo.co.in9441229904

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026